echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Am J Emerg Med: The efficacy of ampicillin in the treatment of brain injury.

    Am J Emerg Med: The efficacy of ampicillin in the treatment of brain injury.

    • Last Update: 2020-08-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Meamincyclic acid has a certain therapeutic effect on traumatic brain injury.
    system review and meta-analysis aimed at studying the efficacy of ampicillin in the treatment of traumatic brain injury.
    researchers systematically searched the Library databases of PubMed, EMbase, Web of Science, EBSCO, and Cochrane, and collected randomized controlled trials (RCTs) on the efficacy of ampicillin in the treatment of traumatic brain injury. A total of 6 RCTs were included in the results of the
    .
    compared to the placebo group, in patients with traumatic brain injury, meaminic acid can significantly reduce mortality (risk ratio (RR) s 0.91; 95% confidence interval (CI) s 0.85 to 0.97; P -0.004) and hemorrhagic lump growth (RR-0.78; 95% CI-0.61 to 0.99), but surgery (0.04), but 99; 95% CI - 0.85 to 1.15; P - 0.92), extracranial surgery (RR s 1.00; 95% CI s 0.97 to 1.04; P - 0.99), bad outcome (Glasgow results scale, GOS) RR (0. 72; 95% CI - 0.47 to 1.11; P - 0.14), pulmonary embolism (1.86; 95% CI - 0.42 to 8.29; P - 0.42) and deep vein thrombosis (RR - 0.97; 95% CI - 0.64 to 1.47; P RR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
    in general, the results showed that meamincyclic acid was associated with significantly reduced mortality and growth of hemorrhagic lumps in patients with traumatic brain injury, but the need for neurosurgery and extracranial surgery and the risk of adverse outcomes (GOS) were similar between ampicillin and placebo.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.